News related to Acular (Ketorolac Ophthalmic) and/or conditions it is approved for
Diabetic Macular Edema: Dexamethasone Implant May Improve Vision
Source: Medscape Ophthalmology Headlines [2016.09.22]
A dexamethasone implant improved best-corrected visual acuity and the physiological morphology of the outer retinal layers in a case series of patients with recalcitrant diabetic macular edema.
Medscape Medical News
Source: MedicineNet Eyeglasses, Sunglasses, and Magnifiers Specialty [2016.05.06]
Title: Macular Degeneration
Category: Diseases and Conditions
Created: 7/23/1999 12:00:00 AM
Last Editorial Review: 5/6/2016 12:00:00 AM
Jetrea Gets FDA Nod for Macular Adhesion
Source: MedPage Today Product Alert [2012.10.19]
WASHINGTON -- The FDA has approved ocriplasmin (Jetrea) as the first nonsurgical treatment for symptomatic vitreomacular adhesion.
'Miniature Telescope' for Eye Approved for Macular Degeneration
Source: MedicineNet Macular Degeneration (Age-Related Type) Specialty [2010.07.07]
Title: 'Miniature Telescope' for Eye Approved for Macular Degeneration
Category: Health News
Created: 7/6/2010 2:10:00 PM
Last Editorial Review: 7/7/2010
Are Oral Bisphosphonates Associated With Wet AMD?
Source: Medscape Ophthalmology Headlines [2016.09.23]
With the rising prevalence of oral bisphosphonate use and wet age-related macular degeneration, we must ask ourselves if the two are related.
Gene therapy in a droplet could treat eye diseases, prevent blindness
Source: Eye Health / Blindness News From Medical News Today [2016.07.28]
Eye diseases such as diabetic retinopathy and age-related macular degeneration are among the leading causes of irreversible vision loss and blindness worldwide.
Ruboxistaurin (RBX) may reduce risk of vision loss in diabetics
Source: The Doctors Lounge - Endocrinology and Diabetes
Phase III trial demonstrates ruboxistaurin (RBX) may reduce the risk of vision loss especially in diabetic macular edema.